Speakers line-up  

(individual bios will follow soon - last update 28/01/2019)

Resident's workshop

Dr. Carla Rohrer Bley


DACVR-RO – since 2003, DipECVDI add Rad Oncol – since 2011, Master of Applied Ethics, ASAE since 2015

Since 03/2007     Head of Oncology / Radiation Oncology Vetsuisse Faculty, University of Zürich

Since 08/2015    Head of Oncology / Radiation Oncology: Professor for Radiation Oncology, Vetsuisse Faculty, University of Zurich (Leading group of radiation oncologists, medical oncologists as well as radiation biologists providing clinical treatments as well as clinical and basic research. Only Faculty in Europe that is approved to provide a residency training program in radiation oncology under the ACVR. Interrelation of tumor microenvironment with various forms of anticancer therapy, especially different radiation fractionation schedules. DNA damage and –repair after ionizing radiation. Treatment planning in animal cancer therapy, especially tumors of the nervous system and nasosinal neoplasia).

Dr. Jérôme Benoit


Jérôme Benoit completed an ACVR residency from North Carolina State University and passed his certifying examination in radiation oncology in 2010. He is currently working as Head of Radiation Oncology for the past 5 years in Oncovet (France) where he has been able to develop a unique experience and expertise in Brachytherapy for various neoplasia including newer indications in small and large animals.

Dr. Julia Buchholz


After her vet studies in Giessen & Nantes Julia accomplished her doctoral thesis on Photodynamic Therapy at the University Zurich. After her residency at Zurich & Colorado State University she gained her Diploma in Radiooncology & then worked as Visiting Assistant Professor at Louisiana State University before helping to set up the Radiation Oncology Facility at the COV in Italy. 

2008-2018: Head of Radiooncology at the AOI Center in Switzerland.

In 2018 she worked as Radiooncology Consultant at the University Munich. Since summer 2018 Julia works at the Veterinary Clinic Hofheim, as Oncology Consultant for Idexx and from 2019 on as Radiation Oncology Consultant for the COV in Italy. Over the past 15 years she presented at national & international meetings, wrote scientific articles & book chapters. 


Thursday 23rd May - Themed Session: 'Histiocytic Proliferative Diseases'

Dr. Jérôme Abadie

Dr. Benoit Hedan


I am a veterinary specialized in dog genetics as a means to decipher genetic disease or multifactorial diseases as cancers for benefit of dog and human’s medicine . I obtained my diploma of veterinary medecine (DVM) from the veterinary school of Nantes, France, in 2003.

I completed a PhD in canine genetics at the University of Rennes, France. During my PhD, I focused on genetic bases of monogenic traits ( ex. merle coat color in Australian Shepherd dogs) as also polygenic disease (ex. histiocytic sarcoma in bernese mountain dogs).

To continue my interest in the genomics of canine cancer, I performed a Post Doctoral position in Pr M. Breen’s lab, Raleigh, NCSU,USA, in 2008-2010. Using array based CGH and FISH techniques, I looked for the cytogenetic anomalies/genome lesions associated histiocytic malignancies in high risk breeds.

I was hired by CNRS in 2012 in the dog genetics team where I am now working and supervising studies on predisposing and acquired alterations in different cancers in dogs (histiocytic sarcoma, lymphoma,…).

These approaches highlighted chromosomic regions involved in histiocytic sarcoma predisposition in Bernese Mountain Dogs. This allowed us, in collaboration with the private Antagene company,  to develop a genetic tools to help breeders to manage selection against this devastating cancer.

Dr. Jane Dobson


Dr Jane M Dobson MA BVetMed, DVetMed,   DipECVIM-CA [IntMed][Oncol](add RadOnc)   FRCVS

University Reader in Veterinary Oncology, Associate Clinical Dean & Deputy Head of Department, Department of Veterinary Medicine, University of Cambridge

Graduate of the Royal Veterinary College, worked as houseman / registrar at the Beaumont Hospital (RVC) before studying comparative oncology at the Royal Marsden Hospital, London.  In 1984, moved to Cambridge as research assistant working on hyperthermia in the treatment of cancer, leading to DVetMed in 1989. Received BSAVA Woodrow award in 1994,  Diplomate of ECVIM-CA, Internal Medicine in 1997, received BSAVA Blaine award in 2001. Founding Diplomate in the subspeciality of Oncology in ECVIM, 2004 and founding member of the European Radiation Oncology Education & Credentials Committee, 2013.  RCVS recognized specialist in Veterinary Oncology.  Awarded Fellowship of RCVS 2016 for meritorious contribution to Clinical Practice. Main interests are in anti-cancer chemotherapy, radiotherapy and research into breed associated tumours in dogs.  Co-author of Small Animal Oncology, co-editor of 2nd& 3rdedition of the BSAVA Manual of Canine and Feline Oncology and author of over 100 peer reviewed publications.


Friday 24th May - Themed Session: 'Inflammation and Cancer'

prof. David Argyle


David J. Argyle BVMS PhD DECVIM-CA (Oncology) FRSE FRCVS

David Argyle is a graduate of Veterinary Medicine and Surgery from the University of Glasgow. He gained his PhD in Immunology and Oncology from the same department.  He has served as a clinical academic for the Universities of Glasgow, Wisconsin-Madison and Edinburgh.  He has served as Chair of Clinical Studies and as Postgraduate Dean for the College of Medicine and Veterinary Medicine.  In 2011 he was appointed William Dick chair of Veterinary Clinical Studies and Dean of Veterinary Medicine at The Royal (Dick) School of Veterinary Studies.  He is also deputy head of college for The College of Medicine and Veterinary Medicine. He is chair of the examination board for the ECVIM sub-specialty in Oncology. He is an RCVS and European recognized specialist in veterinary oncology, his major interests are cancer biology and comparative oncology. He was awarded FRSE and FRCVS in 2016 for meritorious contributions to knowledge.

prof. Florian Greten


Prof. Dr. med. Florian R. Greten, Director Georg-Speyer Haus Institute for Tumor Biology and Experimental Therapy, Frankfurt-am-Main.

Since 08/2013 Chair of Tumor Biology (W3), Medical Faculty, Goethe University Frankfurt and Scientific Director, Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt.

2010 – 2013 Professor of Molecular Gastrointestinal Oncology (W2), Klinikum rechts der Isar, Technical University Munich. 

Specialty and Present Interest: Tumor Microenvironment, Colon Cancer, Cancer Stem Cells.


Dr. Lisa Pang


Lisa Pang completed her PhD in cancer cell signalling at the University of Edinburgh. During her PhD, Lisa identified a novel p21 feedback loop in the regulation of p53. Lisa also worked at KuDOS Pharmaceuticals in Cambridge developing novel small molecule inhibitors against members of the phosphoinositide 3-kinase related kinase family, with the aim of sensitising cancer cells to DNA damage. Lisa is now a Research Fellow at The Roslin Institute. The focus of her research is on unravelling the biology of cancer stem cells and further understanding the molecular mechanisms driving tumour repopulation after therapy. 

Dr. Sabine Grösch


Associate Professor, group leader, Institute of Clinical Pharmacology, pharmazentrum frankfurt, Goethe University Frankfurt

2012-present Postdoctoral fellow, group leader, Institute of Clinical Pharmacology, pharmazentrum frankfurt, Goethe University Frankfurt

1999-2012 Postdoctoral fellow, Institute of Applied Toxicology Johannes Gutenberg University, Mainz March 1999-June 1999

Research profil: Pharmacology, Lipids, Prostaglandins, Sphingolipids, Cancer; Colon, Inflammation

Member of the editorial board: Frontiers in PharmacologyInflammation Pharmacology

Member of scientific society: Deutsche Krebsgesellschaft e.V.; Sphingolipid club; DGPT


Saturday 25th May - Themed Session : 'Pathologist - Clinician Interaction'

Prof. Marije Risselada


Dr Marije Risselada received her DVM from Ghent University in Belgium, and continued on in Ghent for a small animal rotating internship and an ECVS Small Animal Surgery residency. She successfully passed the ECVS certifying examination in 2005 and completed a PhD in 2006 before moving to Florida in 2007. While working as Faculty at the University of Florida she completed an ACVS Small Animal Surgery residency in 2011 and passed the ACVS certifying exam in 2012. In 2011 Dr Risselada moved to North Carolina to join the NCSU Soft Tissue service as a Clinical Assistant Professor, and moved into an Assistant Professor position in 2014. In 2017, Dr Risselada joined the Purdue University Small Animal Surgery section, where she currently works as an Assistant Professor in Small Animal Surgery.

She has served on the Veterinary Surgery Editorial board and the Resident Credentialing Committee, and is currently an Associate Editor for Veterinary Surgery and the Journal of Small Animal Practice, and is a member of the Veterinary Society of Surgical Oncology. Dr Risselada has published over 30 peer reviewed paper and her main interests are surgical oncology and novel strategies for medication delivery, in collaborative funded research efforts.

Dr. Annika Herrmann


Annika studied veterinary medicine at the University of Giessen, Germany graduating in 2006. She then took on a residency while researching for her doctoral thesis at the Institute of Veterinary Pathology in Giessen.

In 2009 she moved on to take a position as toxicologic and discovery pathologist at F. Hoffmann-La Roche, Basel, Switzerland; she certified as European Veterinary Specialist in Pathology (DECVP) in 2011. In her position at Roche, Annika was the pathology specialist in various pharmaceutical research projects in the areas of neuroscience, rare diseases and oncology. From this time, Annika maintains a keen interest in basic principles of pathogenesis, and in particular the pathophysiology of cancer.

In 2015, Annika transitioned from her industry role to take on a position as diagnostic pathologist at Bridge Pathology (Synlab VPG), where she enjoys the exposure to a varied and challenging case load comprising to a large extend submissions from the majority of the leading veterinary referral centers in the UK.

Dr. Jérôme Abadie


Dr Jérôme ABADIE, Dr. med. vet. PhD, Diplomate ECVP (Pathology) 

Jérôme Abadie is a graduate of Veterinary Medicine and Surgery from the National Veterinary School of Toulouse, France. He completed a residency in Veterinary Pathology from the National Veterinary School of Nantes and was recognized as French specialist in Pathology since 1997. He then gained his Veterinary Doctorate in Oncology (dedicated to pronostic significance of proliferation indexes in mast cell tumors) and a PhD in biological sciences from the Rennes University focusing on gene transfer and gene therapy, both in 2001.  Since 2002, he has served as an academic teacher and researcher in veterinary pathology for the Veterinary School of Nantes.  Jérôme Abadie is Member of the Board of the European Society of Veterinary Pathology and serves as Chair of the Joint Scientific Committee of both the European Society and College of Veterinary Pathology. His major interests are cancer biology and comparative pathology in oncology, with special emphasis in characterizing canine cancers as models for human oncology, including mammary cancers, histiocytic sarcomas and melanomas.


Saturday 25th May - Technician's Program

Linda Ryan


Linda started her nursing career in general practice, qualifying in 2002. She then spent many years working in specialist clinics at two university referral hospitals. She has attained the Diploma in Advanced Nursing (Medical), as well as a Veterinary Technician Speciality (Oncology). She is a qualified animal trainer, behaviour practitioner and, in 2018, Linda became a Veterinary Technician Specialist in Behaviour. She is passionate about collaborative care and patient-friendly practice, marrying clinical best practice, with welfare-centred care. She
regularly teaches & writes on various related topics, & continues to study in the field of veterinary nursing, animal behaviour & welfare.

prof. David Argyle


David J. Argyle BVMS PhD DECVIM-CA (Oncology) FRSE FRCVS

David Argyle is a graduate of Veterinary Medicine and Surgery from the University of Glasgow. He gained his PhD in Immunology and Oncology from the same department.  He has served as a clinical academic for the Universities of Glasgow, Wisconsin-Madison and Edinburgh.  He has served as Chair of Clinical Studies and as Postgraduate Dean for the College of Medicine and Veterinary Medicine.  In 2011 he was appointed William Dick chair of Veterinary Clinical Studies and Dean of Veterinary Medicine at The Royal (Dick) School of Veterinary Studies.  He is also deputy head of college for The College of Medicine and Veterinary Medicine. He is chair of the examination board for the ECVIM sub-specialty in Oncology. He is an RCVS and European recognized specialist in veterinary oncology, his major interests are cancer biology and comparative oncology. He was awarded FRSE and FRCVS in 2016 for meritorious contributions to knowledge.

dr. Michael Schmohl


Dr. Michael Schmohl, radiologist and surgeon in Tierklinik Hofheim

Education

2009-2013 postgraduate specialization in small animal radiology (Fachtierarzt)

2007 doctorate Free University Berlin

2004 graduation Free University Berlin

2001 exchange student, Maisons-Alfort, Paris, France

1998 -2004 study of veterinary medicine, Free University Berlin

Career

2013 – present partnership in veterinary clinic Hofheim

2007-2013 assistant in veterinary clinic Hofheim

2004-2007 doctorate at Free University Berlin, clinic for horses

2001-2004 student employee clinic for horses, Free University Berlin

Sarah Holliday


Sarah Holliday, Registered Veterinary Nurse C&GCertens.

Sarah qualified in 2008 and started her nursing career in general practice. She spent many years working in all areas of general practice including orthopaedics, wildlife and emergency and critical care. She has certificates in feline and canine behaviour and nursing exotic species. 

Sarah is the Senior Medical Oncology nurse in a large oncology and soft tissue hospital. She works within the medical oncology team to maintain patient welfare and deliver a gold standard of anti-cancer treatment for both clients and their pets.

Her main interests are palliative and end of life stage care. She has published a number of articles in Veterinary nursing journals on oncology related topics & continues to study in the field of veterinary oncology. 

dr. Jarno Schmidt


Dr. Jarno Schmidt, Dr. med. vet., Diplomate ECVIM-CA (Oncology), EBVS® European Specialist in Veterinary Oncology, MRCVS, M.A. (mediation & conflict management)

Dr. Schmidt graduated from the School of Veterinary Medicine in Hanover, Germany in 2002. After doing a doctoral degree on Vascular Biology & Tumour Angiogenesis he completed an ECVIM-CA residency in small animal oncology in the United Kingdom (VRCC). Since 2010 he is an EBVS® European Specialist in Veterinary Oncology (Diplomate ECVIM-CA (oncology)) and holds a certificate in small animal internal medicine. Since 2010 he works as senior consultant oncologist and head of medical oncology at the Veterinary Clinic Hofheim in Hofheim, Germany. He lectures internationally on small animal oncology & cytology and co-authored several textbooks. As a part-time coach, corporate trainer and business and health-care mediator he also teaches conflict management and communication skills in emotionally charged contexts to vets and non-vets.